IL6 and neoplasm: Beyond preclinical models, the evidence suggests that human tumor cells can secrete factors into the bone microenvironment, including IL-6 and PTH-related peptide (PTHrP), which increase the RANKL-to-OPG ratio, thereby enhancing osteolysis and promoting tumor progression [40].